ARTICLE | Strategy
Markmanship
January 4, 1999 8:00 AM UTC
SIBI's U.S. Patent No. 5,401,629, which issued in 1995, claims a transcription-based assay (TBA), a method for identifying compounds that produce a physiologic response by interacting with cell surface proteins, including ion channels and cell surface receptors. Cells in the assay contain a transcriptional element that transcribes a reporter gene when the receptor in question is activated...